Last edition
News about "Chen Yuqing"
Fosun Pharma Announces 2026 Interim Results
Fosun Pharma announces its 2026 interim results, highlighting accelerating globalisation and value realisation from its innovative drug portfolio.
Chen Yuqing | 27/08/2026 | By News Bureau
Fosun Pharma and AriBio Sign Global Deal for AR1001 to Treat Alzheimer's
Fosun Pharma and AriBio signed an exclusive global option agreement for AR1001, an investigational Alzheimer’s disease treatment, with a USD 60 million option fee.
Chen Yuqing | 14/05/2026 | By News Bureau | 415
Yao Pharma and Pfizer Sign Exclusive Collaboration Deal
Yao Pharma has entered into an exclusive global licensing agreement with Pfizer, granting rights to develop, manufacture, and commercialise its oral small-molecule GLP-1 receptor agonists, including lead candidate YP05002. The partnership aims to advance next-generation metabolic therapies with worldwide reach.
Chen Yuqing | 10/12/2025 | By Akanki | 168
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy